Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids - Université Toulouse III - Paul Sabatier - Toulouse INP Accéder directement au contenu
Article Dans Une Revue PLoS Pathogens Année : 2023

Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids

Victoria Ramé
  • Fonction : Auteur
Jean-Michel Lagarde
  • Fonction : Auteur

Résumé

Mycobacterium abscessus (Mabs) drives life-shortening mortality in cystic fibrosis (CF) patients, primarily because of its resistance to chemotherapeutic agents. To date, our knowledge on the host and bacterial determinants driving Mabs pathology in CF patient lung remains rudimentary. Here, we used human airway organoids (AOs) microinjected with smooth (S) or rough (R-)Mabs to evaluate bacteria fitness, host responses to infection, and new treatment efficacy. We show that S Mabs formed biofilm, and R Mabs formed cord serpentines and displayed a higher virulence. While Mabs infection triggers enhanced oxidative stress, pharmacological activation of antioxidant pathways resulted in better control of Mabs growth and reduced virulence. Genetic and pharmacological inhibition of the CFTR is associated with better growth and higher virulence of S and R Mabs. Finally, pharmacological activation of antioxidant pathways inhibited Mabs growth, at least in part through the quinone oxidoreductase NQO1, and improved efficacy in combination with cefoxitin, a first line antibiotic. In conclusion, we have established AOs as a suitable human system to decipher mechanisms of CF-driven respiratory infection by Mabs and propose boosting of the NRF2-NQO1 axis as a potential host-directed strategy to improve Mabs infection control.
Fichier principal
Vignette du fichier
Leon-Icaza_2023.pdf (2.35 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Licence : CC BY - Paternité

Dates et versions

hal-04197558 , version 1 (06-09-2023)

Licence

Paternité

Identifiants

Citer

Stephen Adonai Leon-Icaza, Salimata Bagayoko, Romain Vergé, Nino Iakobachvili, Chloé Ferrand, et al.. Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids. PLoS Pathogens, 2023, 19 (8), pp.e1011559. ⟨10.1371/journal.ppat.1011559⟩. ⟨hal-04197558⟩
30 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More